Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) [Phase 2]
Phase 2 study of TAK-007 in adults with relapsed or refractory B-cell non-Hodgkin lymphoma has posted results and remains active but not rec…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies [Phase 1]
Acepodia Biotech's Phase 1 trial of ACE1831 in adults with relapsed/refractory CD20-expressing B-cell malignancies is currently recruiting a…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas [Phase 3]
This document reports the completion of a Phase 3 trial comparing JCAR017 to standard of care in adults with high-risk, transplant-eligible …
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) [Phase 1]
The ASPEN-01 Phase 1 trial of Evorpacept (ALX148) in patients with advanced solid tumors and Non-Hodgkin lymphoma has completed its Phase 1 …
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Living Conditions After Non-Hodgkin's Lymphoma in France
A completed clinical trial in France, sponsored by Centre Hospitalier Universitaire Dijon, evaluating living conditions after Non-Hodgkin ly…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Haplo Peripheral Blood Sct In GVHD Prevention [Phase 1]
Phase 1 trial update reporting the completion of a haploidentical peripheral blood stem cell transplantation approach for the prevention of …
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene [Phase 1]
Phase 1 clinical trial of CASPALLO allodepleted T cells engineered with an inducible caspase-9 suicide gene; the study is currently active b…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies [Phase 1]
Phase 1 clinical trial evaluating human anti-CD19 CAR-T cells for relapsed or refractory lymphoid malignancies is currently active but not r…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR) [Phase 1]
Phase 1 study update for CD19 CAR-allogeneic NKT therapy (ANCHOR) in relapsed or refractory B-cell malignancies; the trial is currently acti…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma
This completed trial update reports on cardiotoxicity and other late effects after radiotherapy combined with immuno-chemotherapy in non-Hod…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Avelumab With Valproic Acid in Virus-associated Cancer [Phase 2]
Phase 2 trial evaluating the PD-L1 inhibitor avelumab in combination with valproic acid for virus-associated cancers has completed; the upda…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating obinutuzumab with GDP chemotherapy in relapsed or refractory non-Hodgkin lymphoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) [Phase 1]
This update covers the completed Phase 1 study of the investigational drug JNJ-67856633 in participants with non-Hodgkin lymphoma and chroni…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Treatment and Natural History Study of Lymphomatoid Granulomatosis [Phase 2]
This is a Phase 2 clinical trial update reporting results for a treatment and natural history study of lymphomatoid granulomatosis; results …
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: A Phase 1 Study of ADI-001 in B Cell Malignancies [Phase 1]
The Phase 1 study of ADI-001 in B cell malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases [Phase 2]
A Phase 2 clinical trial is testing alpha/beta T cell and CD19+ B cell depletion in allogeneic stem cell transplantation for malignant disea…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Palifermin (Kepivance) in patients undergoing unrelated donor allogeneic hematopoietic cell transplant…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies [Phase 1]
Phase 1 study evaluating CD19/CD22 CAR T cells in children and young adults with recurrent or refractory CD19/CD22-expressing B cell maligna…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating the CAR-T therapy C-CAR039 in relapsed/refractory Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-26Clinical Trial Update: Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating direct tumor microinjection and FDG-PET to test drug sensitivity in patients with relapsed or refractory n…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study Evaluating Safety and Efficacy of C-CAR039 Treatment in NHL Subjects [Phase 1]
A Phase 1 study evaluating the safety and efficacy of the CAR-T therapy C-CAR039 in patients with Non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma [Phase 1]
This update notes the completion of a Phase 1 study evaluating C-CAR039 in subjects with relapsed/refractory B-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas [Phase 1]
MIL62 was studied in a Phase 1 trial for CD20-positive B-cell non-Hodgkin lymphoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Administration of T Lymphocytes for Prevention of Relapse of Lymphomas [Phase 1]
Phase 1 clinical trial update evaluating administration of T lymphocytes to prevent relapse in Hodgkin lymphoma and other lymphomas; results…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL) [Phase 1]
Phase 1 study assessing feasibility and safety of UCD19 CD19-directed CAR T cells in adults with relapsed/refractory B-cell non-Hodgkin lymp…